These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36473536)

  • 41. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
    Bootsma H; Spronk PE; Ter Borg EJ; Hummel EJ; de Boer G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
    Bizzaro N; Villalta D; Giavarina D; Tozzoli R
    Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical application of an ELISA technique for the detection of antihistone antibodies.
    Epstein A; Greenberg M; Halbert S; Kramer L; Barland P
    J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.
    Infantino M; Grossi V; Benucci M; Li Gobbi F; Damiani A; Manfredi M
    Lupus; 2018 Jan; 27(1):40-48. PubMed ID: 28587585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases.
    Yuan W; Cao H; Li W; Wu X; Zheng J
    Clin Rheumatol; 2022 Mar; 41(3):899-909. PubMed ID: 34626262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of laboratory tests in the diagnosis of SLE.
    Egner W
    J Clin Pathol; 2000 Jun; 53(6):424-32. PubMed ID: 10911799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
    Almogren A
    Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP; Trabandt A; Grobe N; Werle E
    Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay.
    Jang J; Kim S; Kim HS; Lee KA; Park J; Park Y
    J Int Med Res; 2021 Jun; 49(6):3000605211014390. PubMed ID: 34154430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical evaluation of a new quantitative enzyme-linked immunosorbent assay for detection of double-stranded DNA autoantibodies.
    Bardin N; Ragot C; Sanmarco M
    Ann N Y Acad Sci; 2007 Aug; 1109():511-8. PubMed ID: 17785340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus.
    Yuan W; Cao H; Wan P; Shi R; Zhou S; Zheng J
    Lupus; 2019 Oct; 28(12):1387-1396. PubMed ID: 31570052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.
    ter Borg EJ; Horst G; Hummel E; Limburg PC; Kallenberg CG
    Clin Immunol Immunopathol; 1991 Apr; 59(1):117-28. PubMed ID: 2019007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Choi MY; Clarke AE; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg D; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Costenbader KH; Fritzler MJ
    Ann Rheum Dis; 2022 Aug; 81(8):1143-1150. PubMed ID: 35338033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus.
    Wang Y; Luo P; Guo T; Zou L; Shi J; Chen P
    Medicine (Baltimore); 2020 May; 99(20):e20192. PubMed ID: 32443340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of cut-off value for autoantibodies against double-stranded DNA-complexed nucleosomes based on enzyme linked immunosorbent assay].
    Ohnuma K; Hayashi N; Fukuzumi N; Saito A; Tanaka M; Kumagai S; Kawano S
    Rinsho Byori; 2014 Mar; 62(3):223-30. PubMed ID: 24800496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.